发明名称 EP4 receptor antagonists
摘要 Compounds of formula (I): wherein: R<SUP>2 </SUP>is H or an optionally substituted C<SUB>1-4 </SUB>alkyl group; Y is either -(CH<SUB>2</SUB>)<SUB>n</SUB>-X-, where n is 1 or 2 and X is O, S, S(-O), S(-O)<SUB>2</SUB>, or NR<SUP>N1</SUP>, where R<SUP>N1 </SUP>is selected from H or optionally substituted C<SUB>1-4 </SUB>alkyl, or Y is -C(-O)NR<SUP>N2</SUP>-, where R<SUP>N2 </SUP>is selected from H, and optionally substituted C<SUB>1-7 </SUB>alkyl or C<SUB>5-20 </SUB>aryl; R<SUP>3 </SUP>is an optionally substituted C<SUB>6 </SUB>aryl group linked to a further optionally substituted C<SUB>6 </SUB>aryl group, wherein if both C<SUB>6 </SUB>aryl groups are benzene rings, there may be an oxygen bridge between the two rings, bound adjacent the link on both rings; A is a single bond or a C<SUB>1-3 </SUB>alkylene group; and R<SUP>5 </SUP>is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C<SUB>1-7 </SUB>alkyl, C<SUB>5-20 </SUB>aryl or NR<SUP>N3</SUP>R<SUP>N4</SUP>, where R<SUP>N3 </SUP>and R<SUP>N4 </SUP>are independently selected from optionally substituted C<SUB>1-4 </SUB>alkyl; (iv) tetrazol-5-yl.
申请公布号 US2008039502(A1) 申请公布日期 2008.02.14
申请号 US20070889570 申请日期 2007.08.14
申请人 ASTERAND UK LIMITED 发明人 OXFORD ALEXANDER W.;DAVIS RICHARD J.;COLEMAN ROBERT A.;CLARK KENNETH L.;CLARK DAVID E.;HARRIS NEIL V.;FENTON GARRY;HYND GEORGE;STUTTLE KEITH A.;SUTTON JONATHAN M.;NEWTON CHRISTOPHER G.
分类号 A61K31/34;A61K31/341;A61K31/4155;A61K31/443;A61P25/06;C07D231/12;C07D231/18;C07D307/54;C07D307/64;C07D307/68;C07D307/77;C07D405/12;C07D407/12;C07D409/12;C07D413/12;C07D417/12;C07D417/14 主分类号 A61K31/34
代理机构 代理人
主权项
地址